# Comparative Study of Strategies for Management of Duchenne Myopathy (DM)

> **NCT03633565** · PHASE4 · UNKNOWN · sponsor: **Assiut University** · enrollment: 45 (estimated)

## Conditions studied

- Myopathy

## Interventions

- **DRUG:** Sildenafil (Phosphodiesterase inhibitors)
- **DRUG:** Prednisolone (Steroids)
- **PROCEDURE:** Mesenchymal stem cell transplantation

## Key facts

- **NCT ID:** NCT03633565
- **Lead sponsor:** Assiut University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2018-09
- **Primary completion:** 2021-09
- **Final completion:** 2021-11
- **Target enrollment:** 45 (ESTIMATED)
- **Last updated:** 2018-08-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03633565

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03633565, "Comparative Study of Strategies for Management of Duchenne Myopathy (DM)". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT03633565. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*